ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured vs HDFC Pharma and Healthcare Fund Direct Plan Growth
NAV, returns and costs — not a recommendation.
 ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured |  HDFC Pharma and Healthcare Fund Direct Plan Growth | |
|---|---|---|
| NAV | ₹46.11 | ₹21.944 |
| NAV date | 2026-09-30 | 2026-09-30 |
| 1 year | +9.79% | +27.80% |
| 3 year (p.a.) | +21.49% | +30.22% |
| 5 year (p.a.) | +15.66% | +30.22% |
| Expense ratio | 0.87% | 0.92% |
| Fund size | ₹6453.52 Cr | ₹3,310.64 Cr |
| Risk | — | Very high |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.